NPIF backs food photographers with an appetite for growth

A Yorkshire photography and video business whose clients include major supermarkets and food producers has secured £250,000 funding from NPIF – Mercia Debt Finance, which is part of the Northern Powerhouse Investment Fund. Powerhouse is a creative content studio specialising in high-end commercial food, fashion and lifestyle photography and video content for leading global brands

Macroeconomic trends in the healthcare sector

As early and growth-stage investors we are obsessed with understanding where value creation will lie in the future. For Mercia’s Life Sciences & Biosciences team, this means focusing on the areas of healthcare where we can have the maximum impact on improving patient outcomes and reducing healthcare system costs. In this article, Dr Ash Patel

Funding is on the radar for corrosion detection technology

A Midland-based company that develops remote sensors for monitoring corrosion in oil and gas pipelines has secured £250,000 of investment from early-stage technology investor, Mercia Fund Managers. This has been met with a further £104,000 from Innovate UK through its investment accelerator pilot programme. The investment will support CorrosionRADAR with developing its technology and business

Outdoor retailer secures £200k funding as it hits the growth trail

An award-winning outdoor goods retailer which has opened its first two stores in 2017 after trading online for over a decade has secured a £200,000 loan from Mercia Fund Managers to support its further growth. Alpkit produces its own-brand high-performance outdoor clothing, equipment and sports kit, as well as custom-made titanium bikes under its Sondor

PsiOxus Therapeutics Receives $15 Million Milestone Payment as Armed Oncolytic Virus Licensed to Bristol-Myers Squibb Achieves CTA

Mercia Technologies PLC portfolio company, PsiOxus Therapeutics, has announced that the Clinical Trial Application for NG-348, an “armed” oncolytic virus for the treatment of solid tumors, has been approved and, per the licensing agreement between the parties, Bristol-Myers Squibb will make a US $15 million milestone payment to PsiOxus. John Beadle, M.D., Chief Executive Officer

Mercia invests £3.5million as part of a £5.0million syndicated investment into Intechnica

Mercia Technologies PLC, the national investment group focused on the funding and scaling of innovative technology businesses with high growth potential from the UK regions, has completed a £3.5million direct investment into Intechnica Limited (Intechnica), a rapidly growing Manchester-based business that provides scalable software solutions to manage high and variable website traffic demand, including the